Zenas Biopharma (ZBIO) to Release Earnings on Tuesday

Zenas Biopharma (NASDAQ:ZBIO - Get Free Report) is projected to release its earnings data before the market opens on Tuesday, March 25th. Analysts expect Zenas Biopharma to post earnings of ($0.92) per share for the quarter.

Zenas Biopharma Stock Up 11.8 %

ZBIO traded up $0.98 on Monday, hitting $9.31. 135,571 shares of the company's stock were exchanged, compared to its average volume of 172,676. Zenas Biopharma has a fifty-two week low of $5.83 and a fifty-two week high of $26.25. The stock has a market cap of $389.15 million and a PE ratio of -2.62.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on ZBIO shares. Guggenheim restated a "buy" rating and set a $45.00 price target on shares of Zenas Biopharma in a research report on Wednesday, March 12th. Wedbush began coverage on Zenas Biopharma in a report on Thursday. They set an "outperform" rating and a $35.00 target price on the stock.

Zenas Biopharma Company Profile

Zenas BioPharma, Inc is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.